Haddad et al., found 18-gene T-cell-inflamed gene expression profile (GEP) to be associated with PD-L1, indicating that GEP may prove helpful in predicting response to anti-PD-1/PD-L1 agents in HNSCC (90). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.